Evaluating the Cancer Risks of Ozempic and Weight Loss Benefits

This chapter delves into the safety issues surrounding Ozempic, focusing on its possible association with pancreatic cancer. It critically examines reporting biases in health databases, balancing the drug's cancer risk against its weight loss benefits in the context of obesity's impact on overall health.